Literature DB >> 17979574

Community-based phase II trial of PCR for CLL/SLL patients.

Neil E Kay, Tait D Shanafelt, John C Byrd, Michael R Grever.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17979574     DOI： 10.1089/cbr.2007.0424

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN： 1084-9785            Impact factor:   3.099


× No keyword cloud information.
  3 in total

1.  Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia.

Authors:  Neil E Kay; Wenting Wu; Brian Kabat; Betsy LaPlant; Thomas S Lin; John C Byrd; Diane F Jelinek; Michael R Grever; Clive S Zent; Timothy G Call; Tait D Shanafelt
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

2.  N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemia.

Authors:  Neil E Kay; Tait D Shanafelt; Timothy G Call; Wenting Wu; Betsy R Laplant
Journal:  Leuk Lymphoma       Date:  2009-04

3.  A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia.

Authors:  Neil E Kay; Paolo Strati; Betsy R LaPlant; Jose F Leis; Daniel Nikcevich; Timothy G Call; Adam M Pettinger; Connie E Lesnick; Curtis A Hanson; Tait D Shanafelt
Journal:  Oncotarget       Date:  2016-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.